top of page
Search

PFE pipeline Swim in a big pond if you're 2nd to jump in

Amit Roy

We examine in detail, the prospects of five near term PFE pipeline assets, slated for the FDA over the next 3 years and find that there are good prospects for securing approval for at least 4 , achieving an aggregate of $8.5bn of incremental sales over the next five years through targeting large markets


SWIM in the seas

Comments


Focus Research
Recent Reseacrh
Archive
Search By Tags
Follow Us on:
Bloomberg: FOVL <go>
ThomsonReuters
FactSet
Captial IQ
  • LinkedIn Classic
  • Twitter Classic

Foveal LLP is authorised and regulated by the Financial Conduct Authority. Firm no: 646980

Registered in England and Wales, No: OC394934. Registered Office: One Fleet Place, London EC4M 7WS, UK

© Foveal LLP & Amit Roy Photography. All rights reserved. Foveal and the foveal logo are registered trademarks of Foveal LLP

bottom of page